NCT03248141 - Understanding Hemophilia A and B Drug Dosage Administration Patterns | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

March 14, 2018

Study Completion Date

March 14, 2018

Conditions

Hemophilia AHemophilia B

Interventions

DRUG

Hemophilia B standard half-life

Benefix

DRUG

Hemophilia B extended half-life

Alprolix

DRUG

Hemophilia A standard half-life

Xyntha and other standard half-life agents

DRUG

Hemophilia A extended half-life

Eloctate and Adynovate

Trial Locations (3)

University of Florida College of Medicine, Gainesville

Cook Children's Medical Center, Fort Worth

Alliance for Childhood Diseases, dba Hemophilia Treatment Center of Nevada, Las Vegas